Crohn’s disease: Signs on your legs, eyes, and mouth - full list of symptoms
CROHN'S disease is a type of inflammatory bowel disease , which causes inflammation of your digestive tract. The symptoms usually start in childhood or early adulthood. (Source: Daily Express - Health)
Source: Daily Express - Health - November 5, 2021 Category: Consumer Health News Source Type: news

COVID Vaccine Spurs Good Response in People With Crohn's, Colitis
Title: COVID Vaccine Spurs Good Response in People With Crohn ' s, ColitisCategory: Health NewsCreated: 11/4/2021 12:00:00 AMLast Editorial Review: 11/5/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - November 5, 2021 Category: Nutrition Source Type: news

Crohn’s disease: Signs in your eyes, mouth, and skin - how to recognise the signs
CROHN'S disease is a lifelong condition where parts of the digestive system become inflamed, and is one type of a condition called inflammatory bowel disease. The exact cause of Crohn's disease is unknown. (Source: Daily Express - Health)
Source: Daily Express - Health - November 1, 2021 Category: Consumer Health News Source Type: news

Risankizumab Has Early and Lasting Benefits in Crohn's Disease Risankizumab Has Early and Lasting Benefits in Crohn's Disease
Risankizumab takes effect within the first few weeks and has enduring effects in Crohn ' s disease, phase 3 trials suggest.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - October 28, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Crohn’s disease: Foods and drinks to avoid a painful flare-up – including some vegetables
A FLARE-UP of Crohn's disease can lead to urgent bowel movements, diarrhoea and excruciating abdominal pain. If you have to live with this health condition, you would want to avoid aggravating it at all costs. (Source: Daily Express - Health)
Source: Daily Express - Health - October 27, 2021 Category: Consumer Health News Source Type: news

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Crohn’s disease: The food increasing your risk of the condition by 80 percent - BMJ study
INFLAMMATORY bowel disease is an umbrella term used to describe two separate conditions caused by a malfunctioning immune system. Both ulcerative and Crohn's disease are characterised by chronic inflammation and irritation in the lining of the digestive tract. (Source: Daily Express - Health)
Source: Daily Express - Health - October 19, 2021 Category: Consumer Health News Source Type: news

Crohn's Disease: No Decline in Stomas Despite Anti-TNF Therapy Crohn's Disease: No Decline in Stomas Despite Anti-TNF Therapy
Despite the increasing use of anti –TNF medications and a low rate of proctectomy, a recent analysis finds no decline in stoma incidence among patients.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - October 13, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Crohn's Disease: No Decline in Stomas With Anti-TNF Therapy Crohn's Disease: No Decline in Stomas With Anti-TNF Therapy
Despite the increasing use of anti –TNF medications and a low rate of proctectomy, a recent analysis finds no decline in stoma incidence among patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2021 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

What Is Crohn's Disease?
Title: What Is Crohn ' s Disease?Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/13/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 13, 2021 Category: Nutrition Source Type: news

Janssen Submits Application Seeking U.S. FDA Approval of STELARA ® (ustekinumab) for the Treatment of Pediatric Patients With Juvenile Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, October 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking expanded approval of STELARA® (ustekinumab) to treat pediatric patients ages 5 years and older with juvenile psoriatic arthritis (jPsA).The filing is supported by extrapolation of data from nine studies across both adult trials in active PsA and adult and pediatric studies in moderate to severe plaque psoriasis, totaling 3,997 patients evaluated across these closely associated dis...
Source: Johnson and Johnson - October 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

How to Maintain Your Social Life When You Have IBD
About two years ago, as Samantha Plevney was dealing with a major Crohn’s disease flare-up, she decided to tell her gastroenterologist how it was affecting her emotional health. “I told him that I’m alive but I’m not living,” she recalls. “Not being able to see my friends because of the uncertainty of my health situation was making me feel worse. I think people with IBD, and their doctors, tend to focus on physical symptoms, and for good reason. But the mental-health effect that comes from social support is huge.” Inflammatory bowel disease (IBD) encompasses two conditions—Cr...
Source: TIME: Health - October 5, 2021 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Source Type: news

New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA ® (ustekinumab) in Older Patients Across Approved Indications
SPRING HOUSE, PENNSYLVANIA, October 4, 2021 – Today, the Janssen Pharmaceutical Companies of Johnson & Johnson announced a new analysis of STELARA® (ustekinumab) pooled safety data from 13 clinical studies across approved indications, showing rates of key safety events among adults 60 years and older treated with STELARA for up to five yearsa were similar to rates observed with placebo during the control phase of these trials.1,b Approved indications included adults with moderately to severely active Crohn’s disease (CD), moderately to severely active ulcerative colitis (UC), moderate to severe plaque psoriasis (P...
Source: Johnson and Johnson - October 4, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

How Do You Get Crohns
How Do You Get Crohn ' s Disease? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 1, 2021 Category: General Medicine Source Type: news

Hospital and ED visits for Crohn's disease higher in rural than urban US populations
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news